Page last updated: 2024-10-24

candesartan cilexetil and Ovarian Hyperstimulation Syndrome

candesartan cilexetil has been researched along with Ovarian Hyperstimulation Syndrome in 2 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Ovarian Hyperstimulation Syndrome: A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, H1
Furugori, K1
Shibata, D1
Harata, T1
Murata, Y1
Mizutani, S1
Ata, B1
Yakin, K1
Alatas, C1
Urman, B1

Trials

1 trial available for candesartan cilexetil and Ovarian Hyperstimulation Syndrome

ArticleYear
Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome.
    Fertility and sterility, 2008, Volume: 90, Issue:3

    Topics: Adult; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Combined Modality Thera

2008

Other Studies

1 other study available for candesartan cilexetil and Ovarian Hyperstimulation Syndrome

ArticleYear
Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series.
    Human reproduction (Oxford, England), 2003, Volume: 18, Issue:6

    Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; B

2003